Hims & Hers (NYSE:HIMS) announced plans to expand its digital health and weight loss services to Canada in 2026, coinciding with the first global availability of generic semaglutide. Beginning in January 2026, Canada will become the first country to offer generic versions of semaglutide, a GLP-1 receptor agonist widely used for weight management under brand names such as Wegovy and Ozempic.
Hims & Hers Health announced plans to expand to Canada in 2026. Hims will offer generic copies of semaglutide drugs in Canada as Novo Nordisk loses patent protection.
Hims & Hers grew Q1 2025 revenue by 111% to $586 million, with adjusted EBITDA nearly tripling to $91 million. Nearly 60% of the 2.4 million subscribers now use personalized treatments, boosting retention and average revenue per user to $84. Despite the Novo Nordisk split, the diversified GLP-1 and weight loss portfolio targets $725 million in 2025 specialty revenue.
11 Aug 2025 (In 4 weeks) Date | | 0.15 Cons. EPS | - EPS |
6 Jun 2025 Date | | 0.01 Cons. EPS | - EPS |
5 May 2025 Date | | 0.12 Cons. EPS | 0.2 EPS |
24 Feb 2025 Date | | 0.22 Cons. EPS | 0.23 EPS |
4 Nov 2024 Date | | 0.04 Cons. EPS | 0.32 EPS |
11 Aug 2025 (In 4 weeks) Date | | 0.15 Cons. EPS | - EPS |
6 Jun 2025 Date | | 0.01 Cons. EPS | - EPS |
5 May 2025 Date | | 0.12 Cons. EPS | 0.2 EPS |
24 Feb 2025 Date | | 0.22 Cons. EPS | 0.23 EPS |
4 Nov 2024 Date | | 0.04 Cons. EPS | 0.32 EPS |
Household & Personal Products Industry | Consumer Defensive Sector | Andrew Dudum CEO | XMUN Exchange | US4330001060 ISIN |
US Country | 1,637 Employees | - Last Dividend | - Last Split | 13 Sep 2019 IPO Date |
Hims & Hers Health, Inc., based in San Francisco, California, operates as a telehealth platform connecting consumers with licensed healthcare professionals across the United States, the United Kingdom, and other international locations. The company leverages its websites and mobile application to offer a variety of carefully selected health and wellness products and services, both on prescription and over-the-counter basis. Its business model focuses on providing convenient access to ongoing healthcare services, including prescription medication refills and consultations with healthcare providers, as well as a wide range of wellness products through direct sales and wholesale partnerships.